Psilera Bioscience

Psilera Bioscience is one of the many young companies trying to make new psychoactive substances.

Psilera Bioscience

The company is currently in the University of South Florida’s TBTI Incubator program.

Psilera has raised a total of U$2.5 million in funding over one round. This was a seed round raised on July 1 2021.

“Reimagining psychoactive natural products as building blocks for the next generation of neurological therapeutics.”

Key Staff

  • Chris Witowski – Founder & CEO
  • Jack von Salm – Founder & CSO


Company Information

Psilera Bioscience Website

May, 2020


B2B Biotech Drug Discovery

Topics of Interest
Alcohol Use Disorder

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


HQ / Office 3201 W Hillsborough Ave, Tampa, FL 33614, USA